Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.10
+0.07 (1.00%)
At close: Jul 8, 2026, 4:00 PM EDT
7.20
+0.10 (1.41%)
After-hours: Jul 8, 2026, 6:48 PM EDT
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $799.67 million as of July 8, 2026. Its market cap has increased by 113.53% in one year.
Market Cap
799.67M
Enterprise Value
701.93M
1-Year Change
113.53%
Ranking
Category
Stock Price
$7.10
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $799.67M, an increase of 101.06%. That is a compound annual growth rate of 16.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 775.40M | 124.05% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 894.58M |
| Phathom Pharmaceuticals | 889.62M |
| Theravance Biopharma | 872.79M |
| Geron | 872.47M |
| Alto Neuroscience | 869.63M |
| Oculis Holding AG | 852.68M |
| ARS Pharmaceuticals | 850.04M |
| CytomX Therapeutics | 831.63M |